These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6762278)

  • 21. Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease.
    Stockley RA; Dale I; Hill SL; Fagerhol MK
    Scand J Clin Lab Invest; 1984 Nov; 44(7):629-34. PubMed ID: 6531650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lung biopsies with light microscopic and ultrastructural observations in 34 cases of diffuse pulmonary diseases].
    Wan HY; Deng WW; Zhu QR
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):18-20, 61. PubMed ID: 8082212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The current concepts of the pathogenesis of fibrosing alveolitis].
    Shukurova RA
    Ter Arkh; 1992; 64(1):151-5. PubMed ID: 1523555
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
    Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice.
    Sato A; Hoshino Y; Hara T; Muro S; Nakamura H; Mishima M; Yodoi J
    J Pharmacol Exp Ther; 2008 May; 325(2):380-8. PubMed ID: 18256171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
    Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunopathogenesis and immunology of pulmonary sarcoidosis].
    Podwysocki B
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):779-82. PubMed ID: 2535007
    [No Abstract]   [Full Text] [Related]  

  • 28. Bronchoscopic biopsies and bronchoalveolar lavage.
    Kvale PA
    Chest Surg Clin N Am; 1996 May; 6(2):205-22. PubMed ID: 8724275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic disorders in patients with an active form of pulmonary sarcoidosis].
    Wolska-Goszka L
    Wiad Lek; 1984 May; 37(10):777-81. PubMed ID: 6390975
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution and role of polymorphonuclear leucocytes in inflammatory reactions of asbestosis].
    Lewczuk E; Owczarek H; Staniszewska G
    Med Pr; 1994; 45(6):547-50. PubMed ID: 7854113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979.
    Daniele RP; Henson PM; Fantone JC; Ward PA; Dreisin RB
    Am Rev Respir Dis; 1981 Dec; 124(6):738-55. PubMed ID: 6459046
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis].
    Pohl WR; Schenk E; Umek H; Micksche M; Kummer F; Köhn H
    Wien Klin Wochenschr; 1993; 105(14):387-92. PubMed ID: 8396288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scleroderma and alveolar inflammation].
    Crestani B; Aubier M
    Rev Mal Respir; 1996; 13(1):15-20. PubMed ID: 8650411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
    Hunninghake GW; Crystal RG
    J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.
    Gereke M; Gröbe L; Prettin S; Kasper M; Deppenmeier S; Gruber AD; Enelow RI; Buer J; Bruder D
    Respir Res; 2007 Jul; 8(1):47. PubMed ID: 17610738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological information for the diagnosis of respiratory tract disease].
    Izumi T
    Kokyu To Junkan; 1983 May; 31(5):471-81. PubMed ID: 6227063
    [No Abstract]   [Full Text] [Related]  

  • 38. [The significance of inflammatory mediators for the development and therapy of fibrosing lung diseases].
    Müller-Quernheim J
    Verh Dtsch Ges Inn Med; 1988; 94():360-4. PubMed ID: 3061207
    [No Abstract]   [Full Text] [Related]  

  • 39. Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.
    Wallaert B; Bart F; Aerts C; Ouaissi A; Hatron PY; Tonnel AB; Voisin C
    Thorax; 1988 Jan; 43(1):24-30. PubMed ID: 2832961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New aspects of the theory inflammation (immune inflammation)].
    Strukov AI
    Arkh Patol; 1981; 43(1):3-12. PubMed ID: 6971085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.